120 related articles for article (PubMed ID: 6028049)
1. Collagen-like fragments: excretion in urine of patients with Paget's disease of bone.
Krane SM; Muñoz AJ; Harris ED
Science; 1967 Aug; 157(3789):713-6. PubMed ID: 6028049
[TBL] [Abstract][Full Text] [Related]
2. Urinary polypeptides related to collagen synthesis.
Krane SM; Muñoz AJ; Harris ED
J Clin Invest; 1970 Apr; 49(4):716-29. PubMed ID: 4315304
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of urinary 4-hydroxyproline-containing polypeptides.
Szymanowicz A
J Chromatogr; 1981 Sep; 225(1):55-63. PubMed ID: 7298759
[TBL] [Abstract][Full Text] [Related]
4. [Chromatographic analysis of urinary amino acids in Paget's disease. I : Biochemical study. Isolation and amino acid composition of a urinary peptide specific to this bone disease].
Fabier JL; Viau M; Constans J; Clerc A
Rev Rhum Mal Osteoartic; 1976 Apr; 43(4):249-53. PubMed ID: 1273474
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of glycosaminoglycans and hydroxyproline in Paget's disease of bone, compared with neoplastic invasion of bone.
Bower L; Manley G
J Clin Pathol; 1981 Oct; 34(10):1097-101. PubMed ID: 7309892
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of hydroxyproline, hydroxylysine and hydroxylysine glycosides by patients with Paget's disease of bone and carcinoma with metastases in bone.
Kelleher PC
Clin Chim Acta; 1979 Mar; 92(3):373-9. PubMed ID: 436278
[TBL] [Abstract][Full Text] [Related]
7. [Chromatographic analysis of urinary amino acids in Paget's disease. II : clinical study].
Roques CF; Mazières B; Amigues H; Fournie A; Arlet J; Ruffié R
Rev Rhum Mal Osteoartic; 1976 Apr; 43(4):255-8. PubMed ID: 1273475
[TBL] [Abstract][Full Text] [Related]
8. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
Garnero P; Gineyts E; Schaffer AV; Seaman J; Delmas PD
Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
[TBL] [Abstract][Full Text] [Related]
9. Determination of hydroxyproline polypeptides in urine and blood serum by gel filtration.
Dubovsky J; Meyer RD
Clin Chim Acta; 1975 Jul; 62(2):277-86. PubMed ID: 1097133
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption.
Papapoulos SE; Frölich M
J Clin Endocrinol Metab; 1996 Nov; 81(11):3993-7. PubMed ID: 8923849
[TBL] [Abstract][Full Text] [Related]
11. A column chromatography fractionation of the hydroxyproline-containing urinary peptides with continuous automatic detection.
Szymanowicz A; Malgras A; Cosson R; Randoux A; Borel JP
Ann Biol Clin (Paris); 1975; 33(5):351-8. PubMed ID: 1217759
[TBL] [Abstract][Full Text] [Related]
12. [Modifications of peptide hydroxyprolinuria during Paget's disease and osteoma (author's transl)].
Dakkak R; Goussault Y; Dreux C
Ann Biol Clin (Paris); 1979; 37(4):195-200. PubMed ID: 525849
[TBL] [Abstract][Full Text] [Related]
13. Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.
Garnero P; Fledelius C; Gineyts E; Serre CM; Vignot E; Delmas PD
J Bone Miner Res; 1997 Sep; 12(9):1407-15. PubMed ID: 9286756
[TBL] [Abstract][Full Text] [Related]
14. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine.
Hanson DA; Weis MA; Bollen AM; Maslan SL; Singer FR; Eyre DR
J Bone Miner Res; 1992 Nov; 7(11):1251-8. PubMed ID: 1466251
[TBL] [Abstract][Full Text] [Related]
15. [Relations between urine excretion of hydroxyproline and alkaline serum phophatase in Paget's disease as expression of changes in collagen metabolism].
Mühlbach R
Beitr Orthop Traumatol; 1966 Apr; 13(4):189-96. PubMed ID: 5927636
[No Abstract] [Full Text] [Related]
16. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.
Krane SM; Kantrowitz FG; Byrne M; Pinnell SR; Singer FR
J Clin Invest; 1977 May; 59(5):819-27. PubMed ID: 404321
[TBL] [Abstract][Full Text] [Related]
17. Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone.
Alexandersen P; Peris P; Guañabens N; Byrjalsen I; Alvarez L; Solberg H; Cloos PA
J Bone Miner Res; 2005 Apr; 20(4):588-95. PubMed ID: 15765177
[TBL] [Abstract][Full Text] [Related]
18. [Hydroxyproline excretion in the urine in Paget's osteodystrophia deformans. Comparative clinical, morphological and biochemical studies].
Raab W; Czitober H
Wien Klin Wochenschr; 1967 Feb; 79(5):91-3. PubMed ID: 5591364
[No Abstract] [Full Text] [Related]
19. Evidence of a generalised connective-tissue defect in Paget's disease of bone.
Francis MJ; Smith R
Lancet; 1974 May; 1(7862):841. PubMed ID: 4132793
[No Abstract] [Full Text] [Related]
20. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM
J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
